Exportar registro bibliográfico

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, rampril, and their combination in high-risk patients : The ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) trials (2004)


Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2020